Filing metadata

Accession number
0001209191-23-052233
Form type
Form 4
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Oct 05, 2023
Reporting period
Oct 04, 2023
Description
Insider transaction

Explore SEC Filings Hub